Artificial Intelligence in Drug Discovery: Case Studies and Success Stories
Preclinical Testing: Predicting Efficacy and Toxicity
AI is playing an increasingly vital role in preclinical testing, a critical phase of the Artificial Intelligence in Drug Discovery Market. This application is a key segment, as detailed in reports like the one on the Artificial Intelligence in Drug Discovery Market. AI models can be used to predict a compound's toxicity and potential side effects before it is tested in living organisms. By using AI to screen out molecules that are likely to fail in this early stage, researchers can save significant time and resources. This article could lead a discussion on how AI is reducing the need for animal testing, improving the efficiency of preclinical trials, and paving the way for more successful human trials.
2 Views